1. Determina 662/2013, G.U. n.175 del 27/07/2013
2. Determina G.U. 41/42 del 24/02/2007
3. RCP ARIXTRA 2.5 mg
4. Determina G.U. 278 del 28/11/2017
5. Cohen AT et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomized placebo controlled trial. BMJ 2006; 332(7537):325-9
6. Ageno W et al. Safety and efficacy of low-dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR study. J Thromb Haemost 2012; 10(11):2291-7
7. Mastroiacovo D et al. The safety of Fondaparinux sodium for the treatment of venous thromboembolism. Expert Opinion on Drug Safety 2016; 15:9, 1259-1265
8. Airoldi G, Campanini M. Fondaparinux. Italian Journal of Medicine 2008;2(1):44-52
9. RCP ARIXTRA 5 mg
10. RCP ARIXTRA 7.5 mg
11. RCP ARIXTRA 10 mg
12. RCP ARIXTRA 1.5 mg